Effects of low-fat hard cheese enriched with plant stanol esters on serum lipids and apolipoprotein B in mildly hypercholesterolaemic subjects

European Journal of Clinical Nutrition

Volumn 60, Issue 11, 2006, Pages 1253-1257

  Jauhiainen, T ^a,b   Salo, P ^c   Niittynen, L ^d   Poussa, T ^e   Korpela, R ^a,b,f  

^a VALIO LTD   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Raisio Oyj   (Finland)

^d Nutritionist Leena Niittynen   (Finland)

^e Stat Consulting   (Finland)

^f FOUNDATION FOR NUTRITION RESEARCH   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STANOL ESTER; TRIACYLGLYCEROL;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CHEESE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; FINLAND; FLATULENCE; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS B; CHEESE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; FOOD, FORTIFIED; HUMANS; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MALE; MIDDLE AGED; SITOSTEROLS; TRIGLYCERIDES;

EID: 33750539964     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602445     Document Type: Article

References (24)

1. Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 449-502.
2. Gylling H, Miettinen TA (1994). Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37, 773-780.
3. Gylling H, Puska P, Vartiainen E, Miettinen TA (1999). Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population. J Lipid Res 40, 593-600.
4. Gylling H, Radhakrishnan R, Miettinen TA (1997). Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Circulation 96, 4226-4231.
5. Gylling H, Siimes MA, Miettinen TA (1995). Sitostanol ester margarine in dietary treatment of children with familial hyper-cholesterolemia. J Lipid Res 36, 1807-1812.
6. Hallikainen M, Sarkkinen E, Wester I, Uusitupa M (2002). Short-term LDL cholesterol-lowering efficacy of plant stanol esters. BMC Cardiovasc Disord 2, 14.
7. Hallikainen MA, Sarkkinen ES, Gylling H, Erkkilä AT, Uusitupa MIJ (2000a). Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesteroleamic subjects on a low-fat diet. Eur J Clin Nutr 54, 715-725.
8. Hallikainen MA, Sarkkinen ES, Uusitupa MIJ (2000b). Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr 130, 767-776.
9. Hallikainen MA, Uusitupa MIJ (1999). Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr 69, 403-410.
10. Homma Y (2004). Predictors of atherosclerosis. J Atheroscler Thromb 11, 265-270.
11. Homma Y, Ikeda I, Ishikawa T, Tateno M, Sugano M, Nakamura H (2003). Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: A randomized, placebo-controlled trial. Nutrition 19, 369-374.
12. Ikeda I, Tanabe Y, Sugano M (1989). Effects of sitosterol and sitostanol on micellar solubility of cholesterol. J Nutr Sci Vitaminol 35, 361-369.
13. Mensink RP, Ebbing S, Lindhout M, Plat J, van Heugten MMA (2002). Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis 160, 205-213.
14. Miettinen TA, Puska PP, Gylling H, Vanhanen H, Vartiainen E (1995). Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 333, 1308-1312.
15. Miettinen TA, Vanhanen H (1994). Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis 105, 217-226.
16. Neil HAW, Meijer GW, Roe LS (2001). Randomised, controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis 156, 329-337.
17. Nestel P, Cehun M, Pomeroy S, Abbey M, Weldon G (2001). Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods. Eur J Clin Nutr 55, 1084-1090.
18. Plat J, Mensink RP (2000). Vegetable oil based versus wood based stanol ester mixtures: Effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects. Atherosclerosis 148, 101-112.
19. Plat J, van Onselen ENM, van Heugten MMA, Mensink RP (2000). Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr 54, 671-677.
20. Pollak OJ (1985). Effect of plant sterol on serum lipids and atherosclerosis. Pharmacol Ther 31, 177-208.
21. Stamler J, Daviglus ML, Garside D, Dyer AR, Neaton JD (2000). Relationship of baseline serum cholesterol level in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longvity. JAMA 284, 311-318.
22. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D et al. (1999). Low risk-factor profile and long-term cardiovascular mortality and life expectancy: Findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 282, 2012-2018.
23. Tammi A, Rönnemaa T, Miettinen TA, Gylling H, Rask-Nissilä L, Viikari J et al. (2002). Effects of gender, apolipoprotein E phenotype and cholesterol-lowering by plant stanol esters in children: The STRIP study. Acta Paediatr 91, 1155-1162.
24. Vanhanen HT, Blomqvist S, Ehnholm C, Hyvönen M, Jauhiainen M, Torstila I et al. (1993). Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res 34, 1535-1544.